10x Genomics, Inc. — Director's Dealing 2019

Sep 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2019-09-16

Reporting Person: Kosaraju Sridhar (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-16	Class B Common Stock	J	10833	—	Disposed	0	Indirect
2019-09-16	Class A Common Stock	J	10833	—	Acquired	10833	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-16	Stock Option (right to buy)	$11.48	J	119167	Disposed	2029-05-10	Class B Common Stock (119167)	Direct
2019-09-16	Stock Option (right to buy)	$11.48	J	119167	Acquired	2029-05-10	Class A Common Stock (119167)	Direct

Footnotes

F1: Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering.

F2: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee.

F3: This option, originally for 130,000 shares, of which 10,833 have been exercised, vested as to one forty-eighth of the shares on April 29, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares.